0001437749-14-014801.txt : 20140808 0001437749-14-014801.hdr.sgml : 20140808 20140808160040 ACCESSION NUMBER: 0001437749-14-014801 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140808 DATE AS OF CHANGE: 20140808 EFFECTIVENESS DATE: 20140808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VBI VACCINES INC. CENTRAL INDEX KEY: 0000704159 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 930589534 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-222565 FILM NUMBER: 141027437 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6178303031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: PAULSON CAPITAL (DELAWARE) CORP. DATE OF NAME CHANGE: 20140326 FORMER COMPANY: FORMER CONFORMED NAME: PAULSON CAPITAL CORP DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0707 D LIVE 0000704159 VBI VACCINES INC. 222 THIRD STREET SUITE 2241 CAMBRIDGE MA MASSACHUSETTS 02142 6178303031 DELAWARE PAULSON CAPITAL (DELAWARE) CORP. PAULSON CAPITAL CORP Corporation true Jeff Baxter 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director President and Chief Executive Officer David Anderson 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Senior Vice President, Research Egidio Nascimento 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Chief Financial Officer T. Adam Buckley 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Vice President, Operations and Project Management Marc Kirchmeier 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Vice President, Formulation Development Trent Davis 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Steve Gillis 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Michael Steinmetz 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Alan Timmins 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Michel DeWilde 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Sam Chawla 222 Third Street, Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2014-07-25 false true true Common Stock was issued pursuant to an Agreement and Plan of Merger by and among the Company, Variation Biotechnologies (U.S.), Inc., and VBI Acquisition Corp., attached as Annex A to the Schedule 14A filed with the SEC on June 30, 2014. 0 36356807 36356807 0 Based on 8,554,543 shares issued, on a post 1-for-5 reverse split basis, in connection with the merger and a per share price of $4.25 as of market close on July 25, 2014. true 4 27 367500 0 Middlebury Securities, LLC received 120,000 shares of common stock. Palladium Capital Advisors, LLC received $367,500 and 341,731 shares of common stock. 0 true false VBI VACCINES INC. /s/ Jeff Baxter Jeff Baxter Chief Executive Officer 2014-08-08